Spis treści:
1. REPORT
2. INFORMATION ABOUT THE ENTITY
3. SIGNATURE OF PERSONS REPRESENTING THE COMPANY
Spis załączników:
1. REPORT
2. INFORMATION ABOUT THE ENTITY
3. SIGNATURE OF PERSONS REPRESENTING THE COMPANY
Spis załączników:
- Unaudited interim report of the Krka Group and Krka for the period January to September 2023.pdf Unaudited interim report of the Krka Group and Krka, d. d., for the period January to September 2023
- ESG Policy.pdf ESG Policy
- Press Release.pdf Press Release
| POLISH FINANCIAL SUPERVISION AUTHORITY | |||||||||||
| UNI - EN REPORT No | 42 | / | 2023 | ||||||||
| Date of issue: | 2023-11-16 | ||||||||||
| Short name of the issuer | |||||||||||
| KRKA | |||||||||||
| Subject | |||||||||||
| Unaudited interim report of the Krka Group and Krka, d. d., for the period January to September 2023 and the revised ESG Policy of the Krka Group | |||||||||||
| Official market - legal basis | |||||||||||
| art. 56. 1. 2 of Act on Public Offering. | |||||||||||
| Unofficial market - legal basis | |||||||||||
| Contents of the report: | |||||||||||
| Based on Article 26 of the Rules of the Ljubljana Stock Exchange d.d. company Krka, d. d., Novo mesto publishes The unaudited interim report of the Krka Group and Krka, d. d., Novo mesto in the period January - September 2023 and the ESG revised Policy of the Krka Group. The report will be published on the Company's website (www.krka.biz) from 16 November 2023 onwards, for a period of at least 5 years. | |||||||||||
| Annexes | |||||||||||
| File | Description | ||||||||||
| Unaudited interim report of the Krka Group and Krka for the period January to September 2023.pdf Unaudited interim report of the Krka Group and Krka for the period January to September 2023.pdf | Unaudited interim report of the Krka Group and Krka, d. d., for the period January to September 2023 | ||||||||||
| ESG Policy.pdf ESG Policy.pdf | ESG Policy | ||||||||||
| Press Release.pdf Press Release.pdf | Press Release | ||||||||||
| KRKA, TOVARNA ZDRAVIL D.D. | |||||||||||||
| (fullname of the issuer) | |||||||||||||
| KRKA | Farmaceutyczny (far) | ||||||||||||
| (short name of the issuer) | (sector according to clasification of the WSE in Warsow) | ||||||||||||
| 8501 | Nove Mesto | ||||||||||||
| (post code) | (city) | ||||||||||||
| Smarjeska | 6 | ||||||||||||
| (street) | (number) | ||||||||||||
| +386 7 331 21 11 | +386 7 332 15 37 | ||||||||||||
| (phone number) | (fax) | ||||||||||||
| (e-mail) | (web site) | ||||||||||||
| nie dotyczy | |||||||||||||
| (NIP) | (REGON) | ||||||||||||
| SIGNATURE OF PERSONS REPRESENTING THE COMPANY | |||||
| Date | Name | Position / Function | Signature | ||
| 2023-11-16 | Jože Colarič | President of the Management Board and CEO | |||
20231116_081554_1461213338_ESG_Policy.pdf
20231116_081554_1461213338_Press_Release.pdf
20231116_081554_1461213338_Unaudited_interim_report_of_the_Krka_Group_and_Krka_for_the_period_January_to_September_2023.pdf
